Amphotericin B: current understanding of mechanisms of action.
about
Zygomycetes in human diseaseReactive oxygen species-inducing antifungal agents and their activity against fungal biofilmsPharmacokinetics and pharmacodynamics of antifungals in children: clinical implicationsStructure of Cytochrome P450 PimD Suggests Epoxidation of the Polyene Macrolide Pimaricin Occurs via a Hydroperoxoferric IntermediateA novel membrane protein, Ros3p, is required for phospholipid translocation across the plasma membrane in Saccharomyces cerevisiae.Drs2p-related P-type ATPases Dnf1p and Dnf2p are required for phospholipid translocation across the yeast plasma membrane and serve a role in endocytosis.Inhibition of amphotericin B (Fungizone) toxicity to cells by egg lecithin-glycocholic acid mixed micellesEffect of fasting on temporal variation in the nephrotoxicity of amphotericin B in ratsMolecular dynamics simulation of the structure of dimyristoylphosphatidylcholine bilayers with cholesterol, ergosterol, and lanosterolMixture-based heterocyclic combinatorial positional scanning libraries: discovery of bicyclic guanidines having potent antifungal activities against Candida albicans and Cryptococcus neoformansFungal lethality, binding, and cytotoxicity of syringomycin-EKY-62, a polyene analog of amphotericin B, for treatment of murine candidiasisIn vitro antifungal and fungicidal activities and erythrocyte toxicities of cyclic lipodepsinonapeptides produced by Pseudomonas syringae pv. syringaeFitness trade-offs restrict the evolution of resistance to amphotericin BNLLSS: Predicting Synergistic Drug Combinations Based on Semi-supervised LearningSiderophores; iron scavengers: the novel & promising targets for pathogen specific antifungal therapy.Pentoxifylline modulates activation of human neutrophils by amphotericin B in vitro.Lipid complexing decreases amphotericin B inflammatory activation of human neutrophils compared with that of a desoxycholate-suspended preparation of amphotericin B (Fungizone).Modification of rapid susceptibility assay for antifungal susceptibility testing of Aspergillus fumigatus.New and emerging yeast pathogensCandida albicans sterol C-14 reductase, encoded by the ERG24 gene, as a potential antifungal target siteDisruption of the lipid-transporting LdMT-LdRos3 complex in Leishmania donovani affects membrane lipid asymmetry but not host cell invasionComparative pharmacokinetics of amphotericin B after administration of a novel colloidal delivery system, ABCD, and a conventional formulation to rats.Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B.The endocytic process in CHO cells, a toxic pathway of the polyene antibiotic amphotericin B.Candida infections and their prevention.Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicansNanodisks protect amphotericin B from ultraviolet light and oxidation-induced damage.Amphotericin B and fluconazole affect cellular charge, macrophage phagocytosis, and cellular morphology of Cryptococcus neoformans at subinhibitory concentrationsInteraction between fluconazole and amphotericin B in mice with systemic infection due to fluconazole-susceptible or -resistant strains of Candida albicans.Efficacy of oral cochleate-amphotericin B in a mouse model of systemic candidiasis.Virulence of a phosphoribosylaminoimidazole carboxylase-deficient Candida albicans strain in an immunosuppressed murine model of systemic candidiasis.Effect of amphotericin B on capsule and cell size in Cryptococcus neoformans during murine infectionAntifungal triazoles and polymorphonuclear leukocytes synergize to cause increased hyphal damage to Scedosporium prolificans and Scedosporium apiospermum.Amphotericin B-induced nephrotoxicity: a review.Ion channel behavior of amphotericin B in sterol-free and cholesterol- or ergosterol-containing supported phosphatidylcholine bilayer model membranes investigated by electrochemistry and spectroscopy.Toxicity and antileishmanial activity of a new stable lipid suspension of amphotericin B.It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drugIdentification of yeast genes that confer resistance to chitosan oligosaccharide (COS) using chemogenomics.Universal behavior of membranes with sterols.
P2860
Q24514527-DF516250-608B-48E6-896C-FD31E7AEDC55Q26861656-23E93F8E-8700-480B-BE14-ED9B681CBEF9Q27025299-9AF5E2D0-14B5-49A9-A1CF-E058FF5E6413Q27664192-7FE5358E-BB75-4485-AAAC-A2835CDEA3B2Q27933551-A90EC391-6E5E-4683-877B-F6D3C6C40159Q27939868-25C905CF-9A23-49AC-8CEF-F15D6A1EF0D9Q28328856-8B3D1E5E-315B-4AE3-A42B-F8432ED3C89CQ28343168-DE184100-28E8-4CD2-A979-CFE0D314A500Q28360941-37301D1F-0D42-473F-94FA-B8BDFA8AB898Q28369468-8523ABA9-F302-47D6-B64F-701E80AAE917Q28369592-F396479F-E461-4E79-9F5F-4338BAEFA8B3Q28379319-E0DFCB2C-DFE0-4D30-8154-6572F6E9F0B0Q28379609-F7B11EE9-4D2B-43AD-935D-CBCF62B10A2CQ28534687-67669CA2-7DD0-46E8-A967-BF72AD464D2EQ28552626-C74C6C28-7316-4C66-A258-37073DCD18BCQ30243906-32F3C7A4-7B77-49B9-A2DB-7AB444E6C072Q30311275-17D65DCE-FA7A-48E0-BA88-68E34CB8315EQ30436889-B9AF702A-8325-4C61-9FE7-FC7359D2B548Q30452373-F3C1132A-D79F-4BD5-A2EF-4AC5CD4A48ADQ30452880-2E1F6A3D-6E7C-4921-B0DF-A16DE2E17960Q30827584-68E2E27D-FD00-4405-94E0-6AAB2D057D9BQ33701743-1BC66D9C-F5A8-4144-878F-9187A520243CQ33744215-D0054B82-E6D4-4FAC-960C-F0A455187C8CQ33751411-270A84F8-C7D1-4053-9342-8DEF85D39F9EQ33761253-7D3183EC-6E4A-4EF3-A0A8-D6ADAC2FE521Q33775256-52D4EAEB-7821-4E42-8690-4F05D381646AQ33836717-90D93F36-1DED-4F00-AA30-CC48511D58F7Q33946948-A4731561-F317-4AA4-9A42-F53275692897Q33975989-DC8072C4-9BCF-4369-8D49-F42ED1E54AD2Q33978197-CAB87821-1912-40EE-AB9D-F05647004A03Q33980429-70893FF6-FA8C-46DA-B764-D7BD3A0D9C24Q34006967-6B84612D-254D-4510-A133-96A5A5D0D71FQ34077152-4960FC83-20E2-45D3-89F1-1C5FC407DEB3Q34109768-236F31B5-7367-44AB-9E46-E75570EFDF5FQ34128655-2FE0082A-7216-4BAC-91FB-6CBFD7532EFAQ34179391-8DB9DD08-3D2E-4D98-B89C-BC54D6F06819Q34230457-69E06CEB-C421-440D-97DF-A74482CCE8C2Q34302880-80266B20-8F87-4F9B-AA08-D22CB365CF95Q34315296-6E3988B5-1EDC-4A82-AC11-3E66DF022A73Q34354279-595F9B4E-3D46-44A7-A755-3A9F6D2AA46F
P2860
Amphotericin B: current understanding of mechanisms of action.
description
1990 nî lūn-bûn
@nan
1990 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Amphotericin B: current understanding of mechanisms of action.
@ast
Amphotericin B: current understanding of mechanisms of action.
@en
type
label
Amphotericin B: current understanding of mechanisms of action.
@ast
Amphotericin B: current understanding of mechanisms of action.
@en
prefLabel
Amphotericin B: current understanding of mechanisms of action.
@ast
Amphotericin B: current understanding of mechanisms of action.
@en
P2093
P2860
P356
P1476
Amphotericin B: current understanding of mechanisms of action.
@en
P2093
G S Kobayashi
J Brajtburg
W G Powderly
P2860
P304
P356
10.1128/AAC.34.2.183
P407
P577
1990-02-01T00:00:00Z